Charts

News

25 Mar, 2024
Gainers Stoke Therapeutics (NASDAQ:STOK) shares increased by 77.7% to $11.55 during Monday's after-market session. The company's market ...
06 Feb, 2024
SOUTH SAN FRANCISCO, Calif., Feb. 06, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today announced new research published in the peer-reviewed journal Nature Medicine that supports the clearance of senescent cells in the retina as a therapeutic approach that can lead to long-term improvements in vision in patients with diabetic macular edema (DME). Sustained hyperglycemia fr
19 Jan, 2024
Gainers Talphera (NASDAQ:TLPH) stock increased by 10.2% to $0.97 during Friday's after-market session. The company's market cap stands ...
29 Dec, 2023
In this article, we are going to discuss the 10 Supplements for Longevity and Antiaging: Expert Recommendations. You can skip our detailed analysis and go directly to 5 Supplements for Longevity and Antiaging: Expert Recommendations. The anti-aging and longevity market is undergoing a fascinating transformation, driven by personalized approaches, cutting-edge science, and a growing emphasis on evidence-based […]
12 Dec, 2023
Topline 16-week data expected in the fourth quarter of 2024SOUTH SAN FRANCISCO, Calif., Dec. 12, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [Nasdaq: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that the first patients have been dosed in the Phase 2 ASPIRE study of UBX1325 (foselutoclax), a Bcl-xL inhibitor being evaluated head-to-head against standard of care anti-VEGF in patients with diabetic macular edema
16 Nov, 2023
Wedbushanalyst Andreas Argyrides upgraded the shares ofUnity Biotechnology Inc(NASDAQ: UBX) from Neutral to Outperform ...
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
13 Nov, 2023
SOUTH SAN FRANCISCO, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported financial results for the third quarter ended September 30, 2023. “Following positive efficacy and safety data at 48 weeks from a single injection of UBX1325 (foselutoclax) in patients with diabetic macular edema, we are working to quickly and efficiently advance UBX1325 (foseluto
10 Nov, 2023
SOUTH SAN FRANCISCO, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY” or the “Company”) [Nasdaq: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 2,143,000 shares of common stock, having an exercise price of $8.50 per share, issued by UNITY on August 22, 2022, at a reduced e
17 Oct, 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Here are the best longevity stocks to consider. Each stock listed comes with their unique reasons to buy them. The post Are Longevity Stocks the Next Trillion-Dollar Industry? 3 Anti-Aging Picks appeared first on InvestorPlace. More From InvestorPlace Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. The #1 AI Investment Might Be This Company You’ve Never Heard Of The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors
04 Oct, 2023
In this article, we will be taking a look at the 20 foods consumed by longest living people every day. If you are not interested in the details about market insights on longevity, head straight to the 5 Foods Consumed By Longest Living People Every Day. The pursuit of longevity and vitality has captivated humankind […]
27 Sep, 2023
Patients on combination treatment with UBX1325 and aflibercept from weeks 24-48 maintained vision gains achieved at week 24 on aflibercept alone, with greater vision improvement in patients with more severe disease Patients with prior anti-VEGF treatment and switched to UBX1325 monotherapy at study start maintained visual acuity through 24 weeks and had only a 1.5 letter decrease from baseline at week 48 40% of UBX1325-treated patients did not require anti-VEGF treatment through 48 weeks and 64%
16 Sep, 2023
On September 14, 2023, Anirvan Ghosh, the CEO of Unity Biotechnology Inc (NASDAQ:UBX), sold 1,246 shares of the company's stock.
15 Aug, 2023
In this article, we will be taking a look at the 20 states with the longest life expectancy in America. If you want to skip our detailed analysis of companies that are working on improving life expectancy, you can go directly to see the 5 States With The Longest Life Expectancy In America. Life Expectancy […]
09 Aug, 2023
Over the past 3 months, 4 analysts have published their opinion on Unity Biotechnology (NASDAQ:UBX) stock. These analysts are typically ...
08 Aug, 2023
SOUTH SAN FRANCISCO, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported financial results for the second quarter ended June 30, 2023. “We are focused on rapidly advancing UBX1325 (foselutoclax) into the next clinical study to help patients suffering from diabetic macular edema who receive suboptimal benefit from the current anti-VEGF standard of care,
26 Jun, 2023
Upgrades According to B. Riley Securities, the prior rating for Identiv Inc (NASDAQ:INVE) was changed from Neutral to Buy. Identiv ...
Within the last quarter, Unity Biotechnology (NASDAQ:UBX) has observed the following analyst ratings: Bullish Somewhat ...
21 Jun, 2023
Phase 2b trial is a randomized, double-masked, active-controlled study designed to evaluate the safety and efficacy of UBX1325 (foselutoclax) compared to aflibercept over 24 weeks First novel senolytic therapeutic candidate to be evaluated head-to-head against standard of care anti-VEGF in DME SOUTH SAN FRANCISCO, Calif., June 21, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [Nasdaq: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging
31 May, 2023
Upgrades For The Carlyle Group Inc (NASDAQ:CG), Raymond James upgraded the previous rating of Market Perform to Outperform. For the ...
26 May, 2023
Within the last quarter, Unity Biotechnology (NASDAQ:UBX) has observed the following analyst ratings: Bullish Somewhat ...
09 May, 2023
Unity Biotechnology (NASDAQ:UBX) reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:05 PM. Here's what investors need to ...
SOUTH SAN FRANCISCO, Calif., May 09, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported financial results for the first quarter ended March 31, 2023. “The recent 48-week readout of our Phase 2 BEHOLD study of UBX1325 helped position our novel senolytic small molecule as potentially a transformative therapeutic option for patients with DME,” said Anirvan Ghosh, Ph.D.,
24 Apr, 2023
UNITY Biotechnology Inc(NASDAQ: UBX)announced resultsfrom the long-term follow-up of the Phase 2 BEHOLD study of ...
A single injection of UBX1325 led to a statistically significant and clinically meaningful improvement in Best Corrected Visual Acuity (BCVA) of +6.2 ETDRS letters from baseline at 48 weeks Approximately 53% of UBX1325-treated patients did not require any additional injections through 48 weeks Retinal structure, as measured by central subfield thickness (CST), was maintained in UBX1325-treated patients throughout the duration of the study UBX1325 had a favorable safety and tolerability profile w
23 Apr, 2023
Program Update with retinal expert and senior clinical advisor Robert B. Bhisitkul, M.D., Ph.D., to be held on Monday, April 24 at 5:00 a.m. PT/8:00 a.m. ETSOUTH SAN FRANCISCO, Calif., April 23, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that it will host a program update to discuss its lead program in UBX1325 on Monday, April 24, 2023 at 5:00 a.m. ET/8:00
03 Apr, 2023
On Monday, 76 companies set new 52-week lows. Facts of Interest About Today's 52-Week Lows: CVB Financial ...
29 Mar, 2023
On Wednesday, 81 companies hit new 52-week lows. Intriguing Points From Today's 52-Week Lows: Kohl's ...
Gainers LogicMark, Inc. (NASDAQ: LGMK) shares rose 36.7% to $0.1914 in pre-market trading after the company reported strong ...
28 Mar, 2023
During Tuesday, 95 stocks hit new 52-week lows. Areas of Interest About Today's 52-Week Lows: The largest company ...
Over the past 3 months, 6 analysts have published their opinion on Unity Biotechnology (NASDAQ:UBX) stock. These analysts are typically ...
27 Mar, 2023
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite trading lower on Monday. The Dow traded up 0.91% to ...
Gainers Alimera Sciences (NASDAQ:ALIM) shares moved upwards by 33.2% to $1.8 during Monday's regular session. As of 13:30 EST, this ...
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 59.6% to $0.2513. Crown Electrokinetics said it has entered into ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Codiak BioSciences (CDAK) stock is falling hard on Monday after the company announced plans for an asset sale through a Chapter 11 bankruptcy. The post Why Is Codiak BioSciences (CDAK) Stock Down 52% Today? appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today It doesn’t matter if you have $500 or $5 million. Do this now. Massive Bear Market “Divergence Event” Ahead… And The #1 Way to Play It
U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 100 points on Monday. The Dow traded up 0.42% to ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Unity Biotechnology (UBX) stock is taking a beating on Monday after revealing results from its Phase 2 clinical trial of UBX1325. The post Why Is Unity Biotechnology (UBX) Stock Down 52% Today? appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today It doesn’t matter if you have $500 or $5 million. Do this now. Massive Bear Market “Divergence Event” Ahead… And The #1 Way to Play It
UNITY Biotechnology Inc(NASDAQ: UBX) announced results from Part A of the Phase 2 ENVISION study of UBX1325 in patients with ...
U.S. stocks traded higher this morning, with the Dow Jones gaining around 200 points on Monday. Following the market opening Monday, ...
Gainers Cyclerion Therapeutics (NASDAQ:CYCN) stock rose 33.6% to $0.58 during Monday's pre-market session. The company's market cap ...
15 Mar, 2023
05 Mar, 2023
30 Dec, 2022
Gainers Dermata Therapeutics (NASDAQ:DRMA) shares rose 90.5% to $0.38 during Friday's pre-market session. The market value of their ...
01 Nov, 2022
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Unity Biotechnology (UBX) stock is gaining on Tuesday after the company released results from a Phase 2 clinical trial of UBX1325. The post Unity Biotechnology (UBX) Stock Pops on Positive Study Data appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.
20 Oct, 2022
Thursday saw 177 companies set new 52-week lows. 52-Week Low Highlights: Tesla (NASDAQ:TSLA) was the largest firm by ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips It's time for another dive into the biggest pre-market stock movers as we get a start on Thursday trading with the latest news! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.
19 Oct, 2022
19 Sep, 2022
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Innovative medical technology companies and anti-aging stocks are the subject of much interest on Wall Street The post The Three Best Anti-Aging Stocks to Buy in September appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.
02 Sep, 2022
On Friday, 122 stocks hit new 52-week lows. Facts of Interest About Today's 52-Week Lows: Sony Group (NYSE:SONY) ...
19 Aug, 2022
Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares climbed 135.9% to close at $2.17 on Thursday. Plus Therapeutics, ...
18 Aug, 2022
U.S. stocks traded mixed toward the end of trading, with the Dow Jones dropping around 60 points on Thursday. The Dow traded down ...
Gainers Plus Therapeutics (NASDAQ:PSTV) shares increased by 41.6% to $0.78 during Thursday's regular session. The ...
Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 297% to $3.66. Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) ...
U.S. stocks turned higher midway through trading, with the Nasdaq Composite gaining 50 points on Thursday. The Dow traded up 0.02% to ...
Gainers Plus Therapeutics (NASDAQ:PSTV) stock rose 101.5% to $1.11 during Thursday's pre-market session. The ...
Gainers Plus Therapeutics, Inc. (NASDAQ: PSTV) shares rose 88.7% to $1.04 in pre-market trading after the company was awarded ...
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares climbed 199.6% to close at $7.64 on Wednesday after the company announced ...
16 Aug, 2022
10 May, 2022

Related Articles